Keren Turjeman
- Molecular Biology
- Biomaterials top 5%
- Biomedical Engineering top 10%
- Immunology
- Rheumatology top 10%
- Co-authors
- Yechezkel BarenholzAvi SchroederAlberto GabizónJoseph KostJacob KleinRonit GoldbergGilad SilbertJános Szebeni
- Topics
- RNA Interference and Gene Delivery (7 papers)Nanoparticle-Based Drug Delivery (5 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- IsraelUnited StatesHungary
In The Last Decade
Keren Turjeman
21 papers receiving 996 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 425
- Biomaterials 316
- Biomedical Engineering 296
- Immunology 140
- Rheumatology 95
Countries citing papers authored by Keren Turjeman
This map shows the geographic impact of Keren Turjeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Turjeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Turjeman more than expected).
Fields of papers citing papers by Keren Turjeman
This network shows the impact of papers produced by Keren Turjeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Turjeman. The network helps show where Keren Turjeman may publish in the future.
Co-authorship network of co-authors of Keren Turjeman
This figure shows the co-authorship network connecting the top 25 collaborators of Keren Turjeman. A scholar is included among the top collaborators of Keren Turjeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Turjeman. Keren Turjeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 10 | |
| 4 | 57 | |
| 5 | 53 | |
| 6 | Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccinesbreakdown → | 114 |
| 7 | 7 | |
| 8 | 7 | |
| 9 | 30 | |
| 10 | 27 | |
| 11 | 14 | |
| 12 | 8 | |
| 13 | 51 | |
| 14 | 39 | |
| 15 | 160 | |
| 16 | 64 | |
| 17 | 72 | |
| 18 | 20 | |
| 19 | 238 | |
| 20 | 20 |
About Keren Turjeman
Keren Turjeman is a scholar working on Biomaterials, Surfaces, Coatings and Films and Rheumatology, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Biomaterials (316 citations), Pharmaceutical Science (60 citations) and Surfaces, Coatings and Films (58 citations). Keren Turjeman has collaborated with scholars based in Israel, United States and Hungary. Frequent co-authors include Yechezkel Barenholz, Avi Schroeder, Alberto Gabizón, Joseph Kost, Jacob Klein, Ronit Goldberg, Gilad Silbert, János Szebeni, Yaelle Bavli and Marina A. Dobrovolskaia. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.